Yale Gets It Right

What to know: Yale’s new report on the decline in the public’s trust in colleges and universities blames the colleges and universities themselves.

https://www.nytimes.com/2026/04/15/us/yale-report-colleges-unversities-trust.html

The TPPF take: For an elite institution, this represents unusual honesty.

“The report documents what reformers have long predicted: the leftward skew of faculty (36-to-1 Democrat-to-Republican in key Yale units), rising student fear of expressing dissenting views, and grades inflated to the point that they now carry the value of Monopoly money,” says TPPF’s Tom Lindsay.

For more on higher education, click here.

https://thecannononline.com/yale-finally-says-the-quiet-part-out-loud/


Mexico

What to know: Mexico is going after high-profile cartel members. But are these actions merely symbolic?

https://www.theguardian.com/world/2026/apr/30/mexico-jalisco-cartel-el-mencho-flores

The TPPF take: America has gotten serious about taking on the cartels. Will Mexico follow suit?

“This is a crisis created by Mexico’s regime, which has cooperated for too long with its own cartels and must now reap the predictable result as Americans act to protect themselves,” says TPPF’s Joshua Treviño . “When Americans crack down on cartels, they aren’t doing it only for American interests; they’re also protecting the Mexican majority that yearns for a defense against the cartels.”

For more on Mexico and the cartels, click here.

https://thecannononline.com/america-gets-serious-about-cartels-will-mexico/


EpiPens

What to know: New Mexico has reached a settlement with Mylan, Inc., which produces EpiPens. The state held that Mylan engaged in unfair and anticompetitive practices to raise EpiPen prices.

https://www.santafenewmexican.com/news/local_news/new-mexico-reaches-2-5-million-settlement-with-epipen-producer/article_1304684d-d5c9-4a95-b586-ac296864614f.html

The TPPF take: Those high prices are putting people’s lives at risk.

“There is not a shortage of epinephrine itself,” says TPPF’s Dr. Cliff Porter. “But there are only a few suppliers of EpiPen and similar epinephrine injection devices to pharmacies. Even insurance co-pays are often equal to or higher than paying cash. People are forgoing having life-saving epinephrine and taking their chances.”

For more on EpiPens, click here.

https://thecannononline.com/signing-blank-checks-with-epipens/